Insights of RKIP-Derived Suppression of Prostate Cancer.
Ying Dong1,2,3, Xiaozeng Lin1,2,3, Anil Kapoor1,2,3
1Department of Surgery, McMaster University, Hamilton, ON L8S 4K1, Canada.
Cancers
|December 24, 2021
Summary
Raf kinase inhibitory protein (RKIP) suppresses prostate cancer (PC) metastasis by inhibiting cell invasion and sensitizing tumors to treatment. This review details RKIP
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer (PC) is a leading cause of cancer death in men, with significant prognostic disparities.
- Metastatic PC (mPC) is primarily treated with androgen deprivation therapy (ADT), but resistance often leads to lethal castration-resistant PC (CRPC).
- Understanding the molecular mechanisms driving PC metastasis is crucial for developing effective therapies.
Purpose of the Study:
- To review the tumor-suppressive functions of Raf kinase inhibitory protein (RKIP) in prostate cancer (PC).
- To elucidate the mechanisms by which RKIP inhibits PC metastasis and influences therapeutic response.
- To explore the regulatory network involving RKIP and its impact on PC progression.
Main Methods:
- Review of existing literature on RKIP's role in prostate cancer.
- Analysis of clinical data showing RKIP downregulation in PC and mPC.
- Examination of in vitro and in vivo (xenograft mouse models) studies demonstrating RKIP's anti-metastatic effects.
Main Results:
- RKIP is downregulated in PC, particularly in metastatic and castration-resistant forms.
- RKIP inhibits PC cell invasion, proliferation, and metastasis in preclinical models.
- RKIP suppresses Raf-MEK-ERK signaling, epithelial-mesenchymal transition (EMT), and modulates the extracellular matrix.
- RKIP sensitizes PC cells to therapeutic treatments.
- Expression of RKIP is negatively regulated by Snail, NFκB, and EZH2.
Conclusions:
- RKIP acts as a significant suppressor of prostate cancer metastasis.
- RKIP's mechanisms involve the inhibition of key oncogenic pathways and processes like EMT.
- Targeting RKIP or its regulatory pathways may offer novel therapeutic strategies for managing advanced prostate cancer.
Related Concept Videos
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
02:15Experimental RNAi
6.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K